Skip to main content
. 2017 Dec 13;9(87):35780–35789. doi: 10.18632/oncotarget.23200

Table 5. Risk factors for 30-day mortality in cirrhosis patients.

Factors Univariate analyses Multivariate analyses
HR (95% CI) P HR (95% CI) P
ESBL (positive vs negative) 0.943 (0.481–1.849) 0.864 - -
Hospital-acquired BSI (yes vs no) 1.006 (0.507–1.994) 0.987 - -
Sensitive to the firstly selected antibiotic (resistant vs sensitive) 1.608 (0766–3.379) 0.209 - -
Appropriate empiric therapy within 48 h (no vs yes) 3.173 (1.514–6.647) 0.002 2.581 (1.166–5.715) 0.019
ICU admission (yes vs no) 4.578 (2.323–9.020) 0.000 4.434 (2.130–8.823) 0.000
Gender (male vs female) 0.954 (0.456–1.995) 0.900 - -
Age 1.011 (0.982–1.041) 0.453 - -
Combined with HCC (yes vs no) 1.239 (0.578–2.658) 0.582 - -
HE (yes vs no) 2.320 (1.161–4.635) 0.017 2.379 (1.115–5.073) 0.025
SBP (yes vs no) 1.167 (0.594–2.294) 0.654 - -
Pneumonia (yes vs no) 3.755 (1.750–8.054) 0.001 - -
Child-Pugh grade (C vs A+B) 2.165 (0.979–4.785) 0.056 - -
Septic shock (yes vs no) 3.116 (1.582–6.139) 0.001 - -
MELD at onset of BSI 1.065 (1.019–1.114) 0.006 - -
Final MELD 1.073 (1.044–1.102) 0.000 1.074 (1.044–1.106) 0.000

Note: ICU: Intensive care unit; HE: Hepatic encephalopathy; MELD: Model for end-stage liver diseases; Final MELD: detected at discharged; -: indicated no related data.